Compare TASK & FTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TASK | FTH |
|---|---|---|
| Founded | 2008 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 755.5M | 835.7M |
| IPO Year | 2021 | 2021 |
| Metric | TASK | FTH |
|---|---|---|
| Price | $8.05 | $27.61 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 14 |
| Target Price | $8.50 | ★ $56.67 |
| AVG Volume (30 Days) | ★ 450.3K | 329.1K |
| Earning Date | 11-06-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 120.00 | N/A |
| EPS | ★ 0.50 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.48 | N/A |
| Revenue Next Year | $6.42 | N/A |
| P/E Ratio | $16.52 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.47 | $17.50 |
| 52 Week High | $17.32 | $42.14 |
| Indicator | TASK | FTH |
|---|---|---|
| Relative Strength Index (RSI) | 51.40 | 37.46 |
| Support Level | $7.50 | $23.47 |
| Resistance Level | $8.18 | $36.63 |
| Average True Range (ATR) | 0.39 | 2.50 |
| MACD | -0.07 | -0.87 |
| Stochastic Oscillator | 42.13 | 12.65 |
TaskUs Inc provides outsourced digital services. Its service offerings include Digital Customer Experience consists of omnichannel customer care services, delivered through digital (non-voice) channels, also including learning experience and sales and customer acquisition services; Trust & Safety consists of monitoring, reviewing and managing user and advertiser-generated content on online platforms to ensure it complies with community guidelines, legal regulations and platform specific policies; and AI Services consists of large language model support and high-quality data labeling services, annotation, context relevance and transcription services performed for the purpose of training and tuning machine learning algorithms, enabling them to develop cutting-edge AI systems.
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.